Clinical evaluation of serum free prostate specific antigen (PSA) assay;Evaluation clinique de la mesure de l'antigène spécifique de la prostate (PSA) sous sa forme libre sérique

Progres en Urologie

Volumn 6, Issue 3, 1996, Pages 368-373

  Chautard, Denis ^a   Daver, Alain ^b   Bali, Bruno ^a   Dardari, Jawdat ^a   Debras, Bertrand ^a   Colls, Philippe ^a   Soret, Jean Yves ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b CENTRE PAUL PAPIN   (France)

Author keywords

Benign prostatic hyperplasia; Prostate specific antigen; Prostatic cancer; Screening

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; BLOOD; CLINICAL TRIAL; HUMAN; MALE; MIDDLE AGED; PROSTATE HYPERTROPHY; PROSTATE TUMOR; RETROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 0343956647     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. ABRAHAMSSON P.A., LILJA H. Free and complex forms of prostate specific antigen in serum. Tumour Marker Update, 1994, 6, 1-4.
2. BABAIAN R.J., METTLIN C., KANE R. et al. The relationship of prostate specific antigen to digital rectal examination and transrectal ultrasonography : findings of the American Cancer Society National Prostate Cancer Detection Project. Cancer, 1992, 69, 1195-1200.
3. BJORK T., BJARTELL A., LILJA J., ABRAHAMSSON P.A., DI SAINT'AGNESE A. Occurrence of alpha-1-antichymotrypsin in the PSA-producing prostatic epithelium may be a prerequisite for complex-binding of PSA to alpha-1-antichymotrypsin in blood. J. Urol., 1993, 149, 332A, abstr. 479.
4. CATALONA W.J., SMITH D.S., RATLIFF T.L. et al. Measurement of prostate specific antigen in serum as a screening test for prostate cancer. J. Urol., 1992, 147, 846-851.
5. CATALONA W.J., RICHIE J.P., DEKERNION J.B. et al. Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer : receiver operating characteristic curves. J. Urol., 1994, 152, 2031-2036.
6. CATALONA W.J., SMITH D.S., WOLFERT R.L. et al. Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. J.A.M.A., 1995, 274; 1214-1220.
7. CHRISTENSON A., BJORK T., NILSSON O. et al. Serum prostate specific antigen complexed to alpha-1-antichymotrypsin as an indicator of prostate cancer. J. Urol., 1993, 150, 100-105.
8. COOKSON M.S., FLOYD M.K., BALL T.P., MILLER E.K., SAROSDY M.F. The lack of predictive value of prostate specific antigen density in the detection of prostate cancer in patients with normal rectal examinations and intermediate prostate specific antigen levels. J. Urol., 1995, 154, 1070-1073
9. COONER W.H., MOSLEY B.R , RUTHEFORD C.L. et al. Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. J. Urol., 1990, 143, 1146-1152.
10. HAMMERER P.O., McNEAL J E., STAMEY T.A. Correlation between serum prostatic antigen levels and the volume of the individual glandular zones of the human prostate. J. Urol., 1995, 153, 111-114.
11. HANLEY J.A., Mc NEIL B.J. The meaning and use of the area under a Receiver Operating Characteristic (ROC) curve. Radiology, 1982, 143, 29-36.
12. HANLEY J.A. Mc NEIL B.J. A method of comparing the areas under Receiver Operating Characteristic curves derived from the same cases Radiology, 1983, 148, 839-843.
13. HUBER P.R., MATTARELLI G. STRITTMATTER B., VAN STEENBRUGGE G.J., SCMID H.P., MAURER A. In vivo and in vitro complex formation of prostate specific antigen with alpha 1-antichymotrypsin. The Prostate, 1995, 27, 166-175.
14. LABRIE F., DUPONT A., SUBURU R. et al. Serum prostate specific antigen as a pre-screening test for prostate cancer. J. Urol., 1992, 147, 846-851.
15. LEPOR H., WANG B., SHAPIRO E. Relationship between prostatic epithelial volume and serum prostate-specific antigen levels. Urology, 1994, 44, 199-205.
16. LILJA H., COCKETT A.T.K., ABRAHAMSSON P.A. Prostate specific antigen predominantly forms a complex with alpha-1-antichymotrypsin in blood. Cancer, 1992, 70, 230-234.
17. LILJA H. Regulation of the enzymatic activity of prostate-specific antigen and its reactions with extracellular protease inhibitors in prostate cancer. Scand. J. Clin. Lab. Invest., 1995, 55, 47-56.
18. MALM J., LILJA H. Biochemistry of prostate specific antigen. PSA. Scand. J. Clin. Lab. Invest., 1995, 55, 15-22.
19. MITRUNEN K., PETTERSSON K., PIIRONEN T., BJORK T., LILJA H., LOVGREN T. Dual-label one-step immunoassay for simultaneous measurement of free and total prostate-specific antigen concentrations and ratios in serum Clin. Chem., 1995, 41, 1115-1120.
20. OESLERLING J.E., JACOBSEN S.J., KLEE G.G. et al. Free, complexed and total serum prostate specific antigen : the establishment of appropriate reference ranges for their concentrations and ratios. J. Urol., 1995, 154, 1090-1095.
21. STAMEY T.A., KABALIN J.N., McNEAL J.E., JOHNSTONE I.M., FREIHA F., REDWINE E., YANG N. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients. J. Urol., 1989, 141, 1070-1076.
22. STAMEY T.A., CHEN Z., PRESTIGIACOMO A. Serum prostate specific antigen binding alpha-1-antichymotrypsin : influence of cancer volume location and therapeutic selection of resistant clones. J. Urol., 1994, 152, 1510-1514
23. STENMAN U.H., LEINONEN J., ALFTHAN H., RANNIKKO S., TUHKANEN K., ALFTHAN O. A complex between prostate specific antigen and alpha-1-antichymotrypsin is the major form of prostate specific antigen in serum of patients with prostatic cancer : assay of the complex improves clinical sensitivity for cancer. Cancer Res., 1991, 51, 222-226.
24. TSUKADA T., ARAI T., YOKOYAMA M. Development of a simple method for measuring of free prostate specific antigen in serum preliminary clinical studies. Clin. Chem., 1995, 41, S229-S230.
25. WANG M.C., VALENZUELA L.A., MURPHY G.P. CHU T.M. Purification of human prostate-specific antigen. Invest. Urol., 1979, 17, 159-163.